carmustine has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dallegri, F | 1 |
Patrone, F | 1 |
Frumento, G | 1 |
Sacchetti, C | 1 |
Roberts, RL | 1 |
Aroda, VR | 1 |
Ank, BJ | 1 |
2 other studies available for carmustine and Autosomal Recessive Chronic Granulomatous Disease
Article | Year |
---|---|
Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms.
Topics: Antibody-Dependent Cell Cytotoxicity; Aprotinin; Blood Glucose; Burkitt Lymphoma; Carmustine; Cell L | 1984 |
N-acetylcysteine enhances antibody-dependent cellular cytotoxicity in neutrophils and mononuclear cells from healthy adults and human immunodeficiency virus-infected patients.
Topics: Acetylcysteine; Adolescent; Adult; Antibody-Dependent Cell Cytotoxicity; Antioxidants; Carmustine; C | 1995 |